» Articles » PMID: 11930044

Intracranial Mass Lesions: Dynamic Contrast-enhanced Susceptibility-weighted Echo-planar Perfusion MR Imaging

Overview
Journal Radiology
Specialty Radiology
Date 2002 Apr 4
PMID 11930044
Citations 187
Authors
Affiliations
Soon will be listed here.
Abstract

Dynamic contrast agent-enhanced perfusion magnetic resonance (MR) imaging provides physiologic information that complements the anatomic information available with conventional MR imaging. Analysis of dynamic data from perfusion MR imaging, based on tracer kinetic theory, yields quantitative estimates of cerebral blood volume that reflect the underlying microvasculature and angiogenesis. Perfusion MR imaging is a fast and robust imaging technique that is increasingly used as a research tool to help evaluate and understand intracranial disease processes and as a clinical tool to help diagnose, manage, and understand intracranial mass lesions. With the increasing number of applications of perfusion MR imaging, it is important to understand the principles underlying the technique. In this review, the essential underlying physics and methods of dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging are described. The clinical applications of cerebral blood volume maps obtained with perfusion MR imaging in the differential diagnosis of intracranial mass lesions, as well as the pitfalls and limitations of the technique, are discussed. Emphasis is on the clinical role of perfusion MR imaging in providing insight into the underlying pathophysiology of cerebral microcirculation.

Citing Articles

Bi-exponential diffusion-weighted imaging for differentiating high-grade gliomas from solitary brain metastases: a VOI-based histogram analysis.

Su Y, Wang J, Guo J, Liu X, Yang X, Cheng R Sci Rep. 2024; 14(1):31909.

PMID: 39738411 PMC: 11685987. DOI: 10.1038/s41598-024-83452-x.


A next-generation, histological atlas of the human brain and its application to automated brain MRI segmentation.

Casamitjana A, Mancini M, Robinson E, Peter L, Annunziata R, Althonayan J bioRxiv. 2024; .

PMID: 39282320 PMC: 11398399. DOI: 10.1101/2024.02.05.579016.


Noninvasive assessment of Ki-67 labeling index in glioma patients based on multi-parameters derived from advanced MR imaging.

Hu Y, Zhang K Front Oncol. 2024; 14:1362990.

PMID: 38826787 PMC: 11140042. DOI: 10.3389/fonc.2024.1362990.


Arterial spin labeled perfusion MRI for the assessment of radiation-treated meningiomas.

Manning P, Srinivas S, Bolar D, Rajaratnam M, Piccioni D, McDonald C Front Radiol. 2024; 4:1345465.

PMID: 38562528 PMC: 10982483. DOI: 10.3389/fradi.2024.1345465.


Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast Perfusion.

Lambrecht S, Liu D, Dzaye O, Kamson D, Reis J, Liebig T Brain Sci. 2024; 14(2).

PMID: 38391701 PMC: 10886779. DOI: 10.3390/brainsci14020126.